Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.
Thrombosis and Haemostasis|May 15, 2002
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with AsparaginaseChristoph Male, Peter Chait, Jeffrey S Ginsberg, et al.
Thrombosis and Haemostasis|July 31, 2003
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA studyLesley Mitchell, Maureen Andrew, Kim Hanna, et al.
Research and Practice in Thrombosis and Haemostasis|December 3, 2024
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational TrialGary M Woods, Alexandra Miller, Maua Mosha, et al.
Transfusion|August 5, 2005
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficienciesPedro de Alarcon, Richard Benjamin, Marion Dugdale, et al.
Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.
Pageof 2